Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Clinical trial NCT05711940 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05711940
- Sponsor
- COMPASS Pathways
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2025-11-13
- Enrollment
- 572
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.